Implandata Ophthalmic Products GmbH
Kokenstrasse
Hannover
D-30159
Germany
Tel: 49-511-2204-2580
Fax: 49-511-2204-2589
Website: http://implandata.com
Email: info@implandata.com
About Implandata Ophthalmic Products GmbH
Implandata Ophthalmic Products GmbH is a privately held, ISO 13485 certified medical device company founded in 2010 in Hannover/Germany. Implandata’s product for continuous monitoring of intraocular pressure and e-Health is providing vastly improved quality and quantity of intraocular pressure data, which is key for personalized care and therapy control. Remote patient management will increase glaucoma treatment efficiency and will contribute to cost savings for all stakeholders.YEAR FOUNDED:
2010
LEADERSHIP:
Founders: Max G. Ostermeier and Stefan Meyer
Founder and CTO: Stefan Meyer
JOBS:
Please click here for Implandata Ophthalmic Products GmbH job opportunities.
10 articles about Implandata Ophthalmic Products GmbH
-
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
-
Global Roundup: UK Expands Life Sciences Ecosystem with Formation of We Are Pioneering Group
4/29/2021
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines. -
BioSpace Global Roundup, June 11
6/11/2020
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses. -
BioSpace Global Roundup, March 5
3/5/2020
Life sciences companies from across the globe provide updates on their businesses and pipelines. -
BioSpace takes a quick look at some of the news coming from biotech and pharma companies from across Europe and Asia.
-
First Patient Successfully Implanted with Implandata’s Novel Eye Pressure Sensor for Continual Glaucoma Monitoring
12/3/2018
This first-in-human clinical study is being conducted to validate the suprachoroidally-placed EYEMATE-SC sensor implant for continual monitoring of intraocular pressure.
-
BioSpace Movers and Shakers Sept. 24
9/24/2018
Here's a look at who's making moves in the biotech and pharma world this week. -
Dominick Arena Joins Implandata Ophthalmic Products GmbH Board of Directors as Chairman
9/19/2018
Implandata Ophthalmic Products GmbH is pleased to announce that Dominick Arena is appointed as its Chairman of the Board effective immediately.
-
Successful First-in-Human Testing of Implandata's Next Generation EYEMATE Micro-Sensor for Improved Monitoring of Glaucoma Patients
11/17/2017
Implandata now reports that its optimized next generation EYEMATE micro-sensor implant for intraocular placement has successfully passed first-in-human validation.
-
CE Mark For Implandata's EYEMATE System For Improved Monitoring And Management Of Glaucoma Patients
5/31/2017